Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

ConditionsInflammatory Bowel Diseases Crohn Disease Ulcerative Colitis Indeterminate Colitis Functional Abdominal Pain Syndrome Functional Bowel Disorder Esophageal Diseases Gastroduodenal Disorder Bowel Dysfunction Gallbladder Diseases Sphincter of Oddi Dysfunction Anorectal Disorder

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age6-21

SponsorSeattle Children's Hospital

About this trial

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

Eligibility criteria

Qualifiers

Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)

Disqualifiers

Other serious medical conditions, such as neurological, liver, kidney, or systemic disease

Pregnancy

Tobacco, alcohol, or illicit drug abuse

Trial design

Treatments tested in this trial

Esophagogastroduodenoscopy (EGD) with biopsy
Colonoscopy w/ biopsy

Treatment groups

200 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Seattle Children's Hospital

Lead sponsor

Allen Institute

Collaborator

Source ClinicalTrials.gov